Triumph Victorious With Data To Back Up SmartMouth – NAD
This article was originally published in The Tan Sheet
Triumph Pharmaceuticals' establishment and performance claims for SmartMouth Mouthwash were substantiated under a review by the National Advertising Division
You may also be interested in...
Cancer claims for supplement sent for FTC scrutiny; Mouthwash bad breath claims stink to NAD; and UK iron superiority claim withers.
Perrigo will launch generics of GSK's OTC Voltaren Arthritis Pain drug later in 2020 following FDA approval of its ANDA. GSK, which received FDA's OTC switch approval in February, still hasn't launched the product or indicated when it will.
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.